ALPA LABORATORIES LTD. - 532878 - Results For The Quarter Ended December, 31 2019.
Alpa Laboratories has submitted the results for the quarter ended December, 31 2019.13-02-2020
ALPA LABORATORIES LTD. - 532878 - Results For The Quarter Ended December, 31 2019.
Alpa Laboratories has submitted the results for the quarter ended December, 31 2019.ALPA LABORATORIES LTD. - 532878 - Results For The Quarter Ended December, 31 2019.
Alpa Laboratories has submitted the results for the quarter ended December, 31 2019.Alpa Laboratories Ltd - 532878 - Board Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On 13Th Day Of February, 2020.
ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve The standalone and consolidated financial statement for the quarter ended 31st December, 2019.ALPA LABORATORIES LTD. - 532878 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. Alpa Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.Alpa Laboratories Ltd - 532878 - Clarification sought from Alpa Laboratories Ltd
The Exchange has sought clarification from Alpa Laboratories Ltd on 20th January, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.ALPA LABORATORIES LTD. - 532878 - Shareholding for the Period Ended December 31, 2019
Alpa Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click hereAlpa Laboratories Ltd - 532878 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Megha NeemaDesignation :- Company Secretary and Compliance OfficerAlpa Laboratories Ltd - 532878 - Closure of Trading Window
Alpa Laboratories Limited has submitted the disclosure for Closure of Trading Window.ALPA LABORATORIES LTD. - 532878 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirement) Regulation,2015.
Alpa Laboratories Limited has submitted the Disclosure under regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirement) Regulation,2015 for period ended 30th September, 2019.ALPA LABORATORIES LTD. - 532878 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirement) Regulation,2015.
Alpa Laboratories Limited has submitted the Disclosure under regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirement) Regulation,2015 for period ended 30th September, 2019.